“The Prospective Randomized Trial Evaluating the Efficacy of the Mitomycin C and Cisplatin Regimen (MP) versus Standard First-Line Chemotherapy in Patients With Advanced BRCA1 2-Associated Ovarian Cancer (NCT04747717)”. Voprosy onkologii 68, no. 5 (October 27, 2022): 628–638. Accessed October 15, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/1411.